Global Androgen Deprivation Therapy (ADT) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 310641
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Androgen Deprivation Therapy (ADT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Androgen Deprivation Therapy (ADT) market size is estimated to be worth US$ 5940.3 million in 2021 and is forecast to a readjusted size of USD 8239.5 million by 2028 with a CAGR of 4.8% during review period. Hospital accounting for % of the Androgen Deprivation Therapy (ADT) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Medicine segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Androgen Deprivation Therapy (ADT) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Medicine

Surgery

Other

Market segment by Application, can be divided into

Hospital

Clinic

Other

Market segment by players, this report covers

Pfizer

Astellas Pharma

Johnson & Johnson

Novartis International

Merck

Veru

Sanofi

GlaxoSmithKline

Bayer

Orion

AstraZeneca

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Androgen Deprivation Therapy (ADT) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Androgen Deprivation Therapy (ADT), with revenue, gross margin and global market share of Androgen Deprivation Therapy (ADT) from 2019 to 2022.

Chapter 3, the Androgen Deprivation Therapy (ADT) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Androgen Deprivation Therapy (ADT) market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Androgen Deprivation Therapy (ADT) research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)

1.2 Classification of Androgen Deprivation Therapy (ADT) by Type

1.2.1 Overview: Global Androgen Deprivation Therapy (ADT) Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type in 2021

1.2.3 Medicine

1.2.4 Surgery

1.2.5 Other

1.3 Global Androgen Deprivation Therapy (ADT) Market by Application

1.3.1 Overview: Global Androgen Deprivation Therapy (ADT) Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Androgen Deprivation Therapy (ADT) Market Size & Forecast

1.5 Global Androgen Deprivation Therapy (ADT) Market Size and Forecast by Region

1.5.1 Global Androgen Deprivation Therapy (ADT) Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Androgen Deprivation Therapy (ADT) Market Size by Region, (2017-2022)

1.5.3 North America Androgen Deprivation Therapy (ADT) Market Size and Prospect (2017-2028)

1.5.4 Europe Androgen Deprivation Therapy (ADT) Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size and Prospect (2017-2028)

1.5.6 South America Androgen Deprivation Therapy (ADT) Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Androgen Deprivation Therapy (ADT) Market Drivers

1.6.2 Androgen Deprivation Therapy (ADT) Market Restraints

1.6.3 Androgen Deprivation Therapy (ADT) Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Androgen Deprivation Therapy (ADT) Product and Solutions

2.1.4 Pfizer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Astellas Pharma

2.2.1 Astellas Pharma Details

2.2.2 Astellas Pharma Major Business

2.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Product and Solutions

2.2.4 Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Astellas Pharma Recent Developments and Future Plans

2.3 Johnson & Johnson

2.3.1 Johnson & Johnson Details

2.3.2 Johnson & Johnson Major Business

2.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Product and Solutions

2.3.4 Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Johnson & Johnson Recent Developments and Future Plans

2.4 Novartis International

2.4.1 Novartis International Details

2.4.2 Novartis International Major Business

2.4.3 Novartis International Androgen Deprivation Therapy (ADT) Product and Solutions

2.4.4 Novartis International Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Novartis International Recent Developments and Future Plans

2.5 Merck

2.5.1 Merck Details

2.5.2 Merck Major Business

2.5.3 Merck Androgen Deprivation Therapy (ADT) Product and Solutions

2.5.4 Merck Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Merck Recent Developments and Future Plans

2.6 Veru

2.6.1 Veru Details

2.6.2 Veru Major Business

2.6.3 Veru Androgen Deprivation Therapy (ADT) Product and Solutions

2.6.4 Veru Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Veru Recent Developments and Future Plans

2.7 Sanofi

2.7.1 Sanofi Details

2.7.2 Sanofi Major Business

2.7.3 Sanofi Androgen Deprivation Therapy (ADT) Product and Solutions

2.7.4 Sanofi Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Sanofi Recent Developments and Future Plans

2.8 GlaxoSmithKline

2.8.1 GlaxoSmithKline Details

2.8.2 GlaxoSmithKline Major Business

2.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product and Solutions

2.8.4 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 GlaxoSmithKline Recent Developments and Future Plans

2.9 Bayer

2.9.1 Bayer Details

2.9.2 Bayer Major Business

2.9.3 Bayer Androgen Deprivation Therapy (ADT) Product and Solutions

2.9.4 Bayer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bayer Recent Developments and Future Plans

2.10 Orion

2.10.1 Orion Details

2.10.2 Orion Major Business

2.10.3 Orion Androgen Deprivation Therapy (ADT) Product and Solutions

2.10.4 Orion Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Orion Recent Developments and Future Plans

2.11 AstraZeneca

2.11.1 AstraZeneca Details

2.11.2 AstraZeneca Major Business

2.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Product and Solutions

2.11.4 AstraZeneca Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 AstraZeneca Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Androgen Deprivation Therapy (ADT) Players Market Share in 2021

3.2.2 Top 10 Androgen Deprivation Therapy (ADT) Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Androgen Deprivation Therapy (ADT) Players Head Office, Products and Services Provided

3.4 Androgen Deprivation Therapy (ADT) Mergers & Acquisitions

3.5 Androgen Deprivation Therapy (ADT) New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2017-2022)

4.2 Global Androgen Deprivation Therapy (ADT) Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2017-2022)

5.2 Global Androgen Deprivation Therapy (ADT) Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2028)

6.2 North America Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2028)

6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country

6.3.1 North America Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2028)

6.3.2 United States Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

6.3.3 Canada Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

6.3.4 Mexico Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2028)

7.2 Europe Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2028)

7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country

7.3.1 Europe Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2028)

7.3.2 Germany Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

7.3.3 France Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

7.3.5 Russia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

7.3.6 Italy Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2028)

8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2028)

8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region

8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Region (2017-2028)

8.3.2 China Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

8.3.3 Japan Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

8.3.4 South Korea Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

8.3.5 India Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

8.3.7 Australia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2028)

9.2 South America Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2028)

9.3 South America Androgen Deprivation Therapy (ADT) Market Size by Country

9.3.1 South America Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2028)

9.3.2 Brazil Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

9.3.3 Argentina Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2028)

10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2028)

10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country

10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2028)

10.3.2 Turkey Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

10.3.4 UAE Androgen Deprivation Therapy (ADT) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Androgen Deprivation Therapy (ADT) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Androgen Deprivation Therapy (ADT) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Androgen Deprivation Therapy (ADT) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Androgen Deprivation Therapy (ADT) Revenue (USD Million) by Region (2017-2022)

Table 5. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Androgen Deprivation Therapy (ADT) Product and Solutions

Table 9. Pfizer Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 11. Astellas Pharma Major Business

Table 12. Astellas Pharma Androgen Deprivation Therapy (ADT) Product and Solutions

Table 13. Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 15. Johnson & Johnson Major Business

Table 16. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product and Solutions

Table 17. Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Novartis International Corporate Information, Head Office, and Major Competitors

Table 19. Novartis International Major Business

Table 20. Novartis International Androgen Deprivation Therapy (ADT) Product and Solutions

Table 21. Novartis International Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Merck Corporate Information, Head Office, and Major Competitors

Table 23. Merck Major Business

Table 24. Merck Androgen Deprivation Therapy (ADT) Product and Solutions

Table 25. Merck Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Veru Corporate Information, Head Office, and Major Competitors

Table 27. Veru Major Business

Table 28. Veru Androgen Deprivation Therapy (ADT) Product and Solutions

Table 29. Veru Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Sanofi Corporate Information, Head Office, and Major Competitors

Table 31. Sanofi Major Business

Table 32. Sanofi Androgen Deprivation Therapy (ADT) Product and Solutions

Table 33. Sanofi Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 35. GlaxoSmithKline Major Business

Table 36. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product and Solutions

Table 37. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bayer Corporate Information, Head Office, and Major Competitors

Table 39. Bayer Major Business

Table 40. Bayer Androgen Deprivation Therapy (ADT) Product and Solutions

Table 41. Bayer Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Orion Corporate Information, Head Office, and Major Competitors

Table 43. Orion Major Business

Table 44. Orion Androgen Deprivation Therapy (ADT) Product and Solutions

Table 45. Orion Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 47. AstraZeneca Major Business

Table 48. AstraZeneca Androgen Deprivation Therapy (ADT) Product and Solutions

Table 49. AstraZeneca Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Global Androgen Deprivation Therapy (ADT) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 51. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 52. Breakdown of Androgen Deprivation Therapy (ADT) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Androgen Deprivation Therapy (ADT) Players Head Office, Products and Services Provided

Table 54. Androgen Deprivation Therapy (ADT) Mergers & Acquisitions in the Past Five Years

Table 55. Androgen Deprivation Therapy (ADT) New Entrants and Expansion Plans

Table 56. Global Androgen Deprivation Therapy (ADT) Revenue (USD Million) by Type (2017-2022)

Table 57. Global Androgen Deprivation Therapy (ADT) Revenue Share by Type (2017-2022)

Table 58. Global Androgen Deprivation Therapy (ADT) Revenue Forecast by Type (2023-2028)

Table 59. Global Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2022)

Table 60. Global Androgen Deprivation Therapy (ADT) Revenue Forecast by Application (2023-2028)

Table 61. North America Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2022) & (USD Million)

Table 62. North America Androgen Deprivation Therapy (ADT) Revenue by Type (2023-2028) & (USD Million)

Table 63. North America Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2022) & (USD Million)

Table 64. North America Androgen Deprivation Therapy (ADT) Revenue by Application (2023-2028) & (USD Million)

Table 65. North America Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2022) & (USD Million)

Table 66. North America Androgen Deprivation Therapy (ADT) Revenue by Country (2023-2028) & (USD Million)

Table 67. Europe Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2022) & (USD Million)

Table 68. Europe Androgen Deprivation Therapy (ADT) Revenue by Type (2023-2028) & (USD Million)

Table 69. Europe Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2022) & (USD Million)

Table 70. Europe Androgen Deprivation Therapy (ADT) Revenue by Application (2023-2028) & (USD Million)

Table 71. Europe Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2022) & (USD Million)

Table 72. Europe Androgen Deprivation Therapy (ADT) Revenue by Country (2023-2028) & (USD Million)

Table 73. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2022) & (USD Million)

Table 74. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Type (2023-2028) & (USD Million)

Table 75. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2022) & (USD Million)

Table 76. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Application (2023-2028) & (USD Million)

Table 77. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Region (2017-2022) & (USD Million)

Table 78. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Region (2023-2028) & (USD Million)

Table 79. South America Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2022) & (USD Million)

Table 80. South America Androgen Deprivation Therapy (ADT) Revenue by Type (2023-2028) & (USD Million)

Table 81. South America Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2022) & (USD Million)

Table 82. South America Androgen Deprivation Therapy (ADT) Revenue by Application (2023-2028) & (USD Million)

Table 83. South America Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2022) & (USD Million)

Table 84. South America Androgen Deprivation Therapy (ADT) Revenue by Country (2023-2028) & (USD Million)

Table 85. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Type (2017-2022) & (USD Million)

Table 86. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Type (2023-2028) & (USD Million)

Table 87. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Application (2017-2022) & (USD Million)

Table 88. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Application (2023-2028) & (USD Million)

Table 89. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Country (2017-2022) & (USD Million)

Table 90. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Androgen Deprivation Therapy (ADT) Picture

Figure 2. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type in 2021

Figure 3. Medicine

Figure 4. Surgery

Figure 5. Other

Figure 6. Androgen Deprivation Therapy (ADT) Revenue Market Share by Application in 2021

Figure 7. Hospital Picture

Figure 8. Clinic Picture

Figure 9. Other Picture

Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Androgen Deprivation Therapy (ADT) Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Region (2017-2028)

Figure 13. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Region in 2021

Figure 14. North America Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Androgen Deprivation Therapy (ADT) Market Drivers

Figure 20. Androgen Deprivation Therapy (ADT) Market Restraints

Figure 21. Androgen Deprivation Therapy (ADT) Market Trends

Figure 22. Pfizer Recent Developments and Future Plans

Figure 23. Astellas Pharma Recent Developments and Future Plans

Figure 24. Johnson & Johnson Recent Developments and Future Plans

Figure 25. Novartis International Recent Developments and Future Plans

Figure 26. Merck Recent Developments and Future Plans

Figure 27. Veru Recent Developments and Future Plans

Figure 28. Sanofi Recent Developments and Future Plans

Figure 29. GlaxoSmithKline Recent Developments and Future Plans

Figure 30. Bayer Recent Developments and Future Plans

Figure 31. Orion Recent Developments and Future Plans

Figure 32. AstraZeneca Recent Developments and Future Plans

Figure 33. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players in 2021

Figure 34. Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Androgen Deprivation Therapy (ADT) Revenue Market Share in 2021

Figure 36. Global Top 10 Players Androgen Deprivation Therapy (ADT) Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Androgen Deprivation Therapy (ADT) Revenue Share by Type in 2021

Figure 39. Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Type (2023-2028)

Figure 40. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application in 2021

Figure 41. Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Application (2023-2028)

Figure 42. North America Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2017-2028)

Figure 43. North America Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2017-2028)

Figure 44. North America Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2017-2028)

Figure 45. United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2017-2028)

Figure 49. Europe Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2017-2028)

Figure 50. Europe Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2017-2028)

Figure 51. Germany Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue Market Share by Region (2017-2028)

Figure 59. China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2017-2028)

Figure 66. South America Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2017-2028)

Figure 67. South America Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz